Judit Pallares Quixal
Degree: PhD
jpallares.lleida.ics(ELIMINAR)@gencat.cat
ResearcherID: http://www.researcherid.com/rid/A-6635-2010
Groups
Publications
-
Llobet, David; Eritja, Nuria; Domingo, Monica; Bergada, Laura; Mirantes, Cristina; Santacana, Maria; Pallares, Judit; Macia, Anna; Yeramian, Andree; Encinas, Mario; Moreno-Bueno, Gema; Palacios, Jose; Lewis, Robert E.; Matias-Guiu, Xavier; Dolcet, Xavi
KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels.
AMERICAN JOURNAL OF PATHOLOGY 178 1529-1543. .
-
Velasco, Ana; Pallares, Judit; Santacana, Maria; Gatius, Sonia; Fernandez, Melisa; Domingo, Monica; Valls, Joan; Yeramian, Andree; Encinas, Mario; Dolcet, Xavier; Matias-Guiu, Xavier
Promoter hypermethylation and expression of sprouty 2 in endometrial carcinoma.
HUMAN PATHOLOGY 42 185-193. .
-
Gatius, S; Azueta, A; Velasco, A; Santacana, M; Pallares, J; Matias-Guiu, X
FGFR2 Alterations in Endometrial Carcinoma.
LABORATORY INVESTIGATION 91 442-442. .
-
Aguayo, Rafael; Pallares, Judit; Casanova, Josep M.; Baradad, Manel; Sanmartin, Veronica; Moreno, Sara; Egido, Ramon; Marti, Rosa M.
Squamous cell carcinoma developing in Jadassohn's sebaceous nevus: case report and review of the literature.
Dermatologic Surgery 36 1763-1768. .
-
Llobet, D.; Eritja, N.; Yeramian, A.; Pallares, J.; Sorolla, A.; Domingo, M.; Santacana, M.; Gonzalez-Tallada, F. J.; Matias-Guiu, X.; Dolcet, X.
The multikinase inhibitor Sorafenib induces apoptosis and sensitises endometrial cancer cells to TRAIL by different mechanisms.
EUROPEAN JOURNAL OF CANCER 46 836-850. .
-
Llobet, D.; Pallares, J.; Yeramian, A.; Santacana, M.; Eritja, N.; Velasco, A.; Dolcet, X.; Matias-Guiu, X.
Molecular pathology of endometrial carcinoma: practical aspects from the diagnostic and therapeutic viewpoints.
JOURNAL OF CLINICAL PATHOLOGY 62 777-785. .
-
Pallares, Judit; Santacana, Maria; Puente, Soraya; Lopez, Susana; Yeramian, Andree; Eritja, Nuria; Sorolla, Anabel; Llobet, David; Dolcet, Xavier; Matias-Guiu, Xavier
A review of the applications of tissue microarray technology in understanding the molecular features of endometrial carcinoma.
ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY 31 217-226. .
-
Pallares, Judit; Llobet, David; Santacana, Maria; Eritja, Nuria; Velasco, Ana; Cuevas, Dolors; Lopez, Susana; Palomar-Asenjo, Victor; Yeramian, Andree; Dolcet, Xavier; Matias-Guiu, Xavier
CK2beta is expressed in endometrial carcinoma and has a role in apoptosis resistance and cell proliferation.
AMERICAN JOURNAL OF PATHOLOGY 174 287-296. .
-
Ortega, Eugenia; Marti, Rosa M.; Yeramian, Andree; Sorolla, Anabel; Dolcet, Xavier; Llobet, David; Abal, Leandro; Santacana, Maria; Pallares, Judit; Llombart-Cussac, Antonio; Matias-Guiu, Xavier
Targeted therapies in gynecologic cancers and melanoma.
SEMIN DIAGN PATHOL 25 262-273. .
-
Puente, Soraya; Velasco, Ana; Gallel, Pilar; Pallares, Judit; Perez-Ruiz, Luis; Ros, Susana; Maravall, Javier; Matias-Guiu, Xavier
Metastatic small cell carcinoma to the thyroid gland: a pathologic and molecular study demonstrating the origin in the urinary bladder.
ENDOCRINE PATHOLOGY 19 190-196. .
-
Gallel, Pitar; Pallares, Judit; Dolcet, Xavier; Llobet, David; Eritja, Nuria; Santacana, Maria; Yeramian, Andre; Palomar-Asenjo, Victor; Lagarda, Helena; Mauricio, Didac; Encinas, Mario; Matias-Guiu, Xavier
Nuclear factor-kappaB activation is associated with somatic and germ line RET mutations in medullary thyroid carcinoma.
HUMAN PATHOLOGY 39 994-1001. .
-
Velasco, Ana; Pallares, Judit; Santacana, Maria; Yeramian, Andre; Dolcet, Xavier; Eritja, Nuria; Puente, Soraya; Sorolla, Anabel; Llecha, Nuria; Matias-Guiu, Xavier
Loss of heterozygosity in endometrial carcinoma
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 27 305-317. .
Projects
- Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
- Estudio metabolómico del carcinoma de endometrio en relación a parametros morfológicos y moleculares
- Carcinoma de endometrio. Participación de las vías de señalización, implicadas en la resistencia a la terapia antineoplasica
- CARCINOMA DE ENDOMETRIO. VALORACION DELECCIONES Y AMPLIFICACIONES DE REGIONES CROMOSOMICAS MEDIANTE ARRAYS DE CGH
- Alteraciones de la modulación de la vía RAS-MAPK y PI-3K en el cáncer de endometrio RASSF1A, NORE1A, Sprouty y PI3CA